EurekAlert! -
21 Dec 2017 07:00
(Baylor College of Medicine) For breast cancer, carrying protein CD44s, instead of CD44v, has a survival advantage. Researchers have now discovered a mechanism by which cells can regulate switching between the two proteins, opening options for the development of novel therapeutic strategies to control cancer growth in the future.
Share this Article